About this FactMed analysis covering adverse side effect reports of AIRBORNE patients who developed ALOPECIA.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 4 individuals taking AIRBORNE reported ALOPECIA to the FDA. A total of 20 AIRBORNE drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between AIRBORNE and ALOPECIA. In doing so, we compare AIRBORNE with other drugs that cause ALOPECIA, to help you evaluate whether or not AIRBORNE causes ALOPECIA. Likewise, this page shows the most highly-reported side effects of AIRBORNE, so you can see if ALOPECIA ranks among AIRBORNE's most well-known side effects.
Summary Statistics
Reports of AIRBORNE causing ALOPECIA: 4
Reports of any side effect of AIRBORNE : 20
Percentage of AIRBORNE patients where ALOPECIA is a reported side effect: 20.0000%

FDA reports of any drug causing ALOPECIA : 26203
Average percentage for all medicated patients where ALOPECIA is reported as a complication: 0.1642%

Physician opinion on AIRBORNE as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing AIRBORNE:
MEDICAL DIET ( 3 patients )
DRUG USE FOR UNKNOWN INDICATION ( 3 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 1 patients )
NASOPHARYNGITIS ( 1 patients )
SUPPLEMENTATION THERAPY ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with ALOPECIA:

NEXAVAR (2114 patients)
HUMIRA (1668 patients)
FOSAMAX (1456 patients)
SYNTHROID (1366 patients)
ENBREL (1292 patients)
ASPIRIN (1181 patients)
MIRENA (1047 patients)
LIPITOR (952 patients)
REMICADE (941 patients)
ACCUTANE (842 patients)
METHOTREXATE (809 patients)
CRESTOR (789 patients)
TYSABRI (747 patients)
PREDNISONE (725 patients)
LEVOTHYROXINE SODIUM (690 patients)
PEGASYS (678 patients)
VIOXX (666 patients)
COUMADIN (646 patients)
LYRICA (633 patients)
NEXIUM (617 patients)
NEURONTIN (603 patients)
ZOMETA (589 patients)
SANDOSTATIN LAR (567 patients)
LISINOPRIL (567 patients)
RIBAVIRIN (560 patients)
FORTEO (556 patients)
FOLIC ACID (548 patients)
TOPROL-XL (528 patients)
ARIMIDEX (525 patients)
AVONEX (522 patients)
LAMICTAL (509 patients)
ATENOLOL (508 patients)
ZOLOFT (503 patients)
LEVOXYL (490 patients)
XANAX (484 patients)
SIMVASTATIN (481 patients)
VITAMIN D (477 patients)
CALCIUM (476 patients)
OMEPRAZOLE (457 patients)
PREMARIN (447 patients)
PRILOSEC (436 patients)
LASIX (436 patients)
SEROQUEL (432 patients)
HYDROCHLOROTHIAZIDE (416 patients)
NORVASC (415 patients)
PEG-INTRON (401 patients)
AREDIA (386 patients)
TOPAMAX (373 patients)
DEPAKOTE (371 patients)
PAXIL (371 patients)
COPEGUS (366 patients)
WELLBUTRIN (365 patients)
ZOCOR (364 patients)
AMBIEN (356 patients)
LEXAPRO (352 patients)
CYMBALTA (351 patients)
ACETAMINOPHEN (350 patients)
CELEBREX (346 patients)
KLONOPIN (341 patients)
METFORMIN HCL (338 patients)
VICODIN (333 patients)
ALBUTEROL (325 patients)
ATIVAN (325 patients)
FUROSEMIDE (315 patients)
BYETTA (312 patients)
SINGULAIR (311 patients)
GABAPENTIN (311 patients)
SPIRIVA (308 patients)
POTASSIUM CHLORIDE (306 patients)
CLONAZEPAM (302 patients)
ADVAIR DISKUS 100/50 (301 patients)
TAXOTERE (301 patients)
IBUPROFEN (300 patients)
PREDNISOLONE (300 patients)
LEVAQUIN (299 patients)
OXYCONTIN (299 patients)
PLAVIX (297 patients)
PROTONIX (285 patients)
FEMARA (280 patients)
PREVACID (279 patients)
PREDNISONE TAB (277 patients)
LORAZEPAM (277 patients)
EFFEXOR (274 patients)
XELODA (272 patients)
DIOVAN (264 patients)
ACTONEL (261 patients)
MULTI-VITAMIN (261 patients)
RIBASPHERE (260 patients)
WELLBUTRIN XL (252 patients)
YAZ (250 patients)
AMLODIPINE (244 patients)
DECADRON (241 patients)
ZETIA (241 patients)
REBIF (238 patients)
CYCLOPHOSPHAMIDE (235 patients)
ALPRAZOLAM (234 patients)
CHANTIX (232 patients)
PERCOCET (231 patients)
FISH OIL (228 patients)
MULTI-VITAMINS (222 patients)
DOXORUBICIN HCL (218 patients)
ZYRTEC (218 patients)
PROZAC (217 patients)
METOPROLOL TARTRATE (213 patients)
NEUPOGEN (211 patients)
COREG (209 patients)
AVASTIN (208 patients)
YASMIN (207 patients)
DEXAMETHASONE (203 patients)
ARAVA (203 patients)
FLUOROURACIL (202 patients)
ZOFRAN (201 patients)
VITAMINS (201 patients)
ASCORBIC ACID (200 patients)
ZANTAC (199 patients)
WARFARIN SODIUM (199 patients)
HERCEPTIN (198 patients)
PRADAXA (197 patients)
TEGRETOL (197 patients)
DEPAKOTE ER (196 patients)
FLEXERIL (194 patients)
BENADRYL (194 patients)
VITAMIN B-12 (193 patients)
TAMOXIFEN CITRATE (191 patients)
CARBOPLATIN (191 patients)
CELEXA (190 patients)
REBETOL (190 patients)
ALENDRONATE SODIUM (188 patients)
DEPO-PROVERA (187 patients)
NAPROXEN (184 patients)
TAXOL (183 patients)
DIAZEPAM (183 patients)
TRAZODONE HCL (182 patients)
ABILIFY (182 patients)
PREMPRO (181 patients)
ZYPREXA (181 patients)
PLAQUENIL (181 patients)
COZAAR (180 patients)
DIGOXIN (180 patients)
ALLOPURINOL (179 patients)
VITAMIN E (177 patients)
ORTHO EVRA (177 patients)
VALIUM (176 patients)
GLEEVEC (175 patients)
LANTUS (173 patients)
EPOGEN (173 patients)
BONIVA (173 patients)
PRISTIQ (172 patients)
VALTREX (172 patients)
XOLAIR (170 patients)
TRAMADOL HCL (166 patients)
KEPPRA (160 patients)
METOCLOPRAMIDE (160 patients)
ALLEGRA (159 patients)
REGLAN (158 patients)
AROMASIN (157 patients)
OXYCODONE HCL (153 patients)
ZITHROMAX (152 patients)
SORAFENIB (149 patients)
PEPCID (149 patients)
ALTACE (148 patients)
EFFEXOR XR (148 patients)
PROCRIT (147 patients)
CYTOXAN (146 patients)
RANITIDINE (146 patients)
AMOXICILLIN (145 patients)
TYLENOL (145 patients)
GILENYA (144 patients)
CLARITIN (144 patients)
DIFLUCAN (141 patients)
FASLODEX (141 patients)
CALCIUM CARBONATE (141 patients)
PACLITAXEL (140 patients)
GLUCOPHAGE (140 patients)
TASIGNA (138 patients)
DEPAKENE (138 patients)
MOTRIN (137 patients)
ELIDEL (137 patients)
NITROGLYCERIN (137 patients)
PEGINTERFERON ALFA-2A (135 patients)
HYDROCODONE (134 patients)
ONDANSETRON (133 patients)
INSULIN (133 patients)
ACTOS (133 patients)
CAPECITABINE (132 patients)
COLACE (132 patients)
LORTAB (131 patients)
AVANDIA (130 patients)
HYZAAR (130 patients)
BETASERON (130 patients)
COMPAZINE (130 patients)
THYROID TAB (129 patients)
BENICAR (128 patients)
NO CONCURRENT MEDICATION (128 patients)
DOXYCYCLINE (128 patients)
SYMBICORT (127 patients)
TRICOR (127 patients)
GEMZAR (126 patients)
FLUCONAZOLE (125 patients)
RITUXIMAB (124 patients)
ALL OTHER THERAPEUTIC PRODUCTS (124 patients)
LOPRESSOR (124 patients)
CEPHALEXIN (124 patients)
SORAFENIB (RAF KINASE INHIBITOR) (124 patients)
TYLENOL (CAPLET) (123 patients)
CLINDAMYCIN (123 patients)
HEPARIN SODIUM INJECTION (123 patients)
IFOSFAMIDE (122 patients)
CLONIDINE (121 patients)
METOPROLOL (120 patients)
Most common side effects for patients taking AIRBORNE:
ALOPECIA (4 patients)
CONFUSIONAL STATE (4 patients)
AGEUSIA (3 patients)
ARTHRALGIA (3 patients)
LIGAMENT OPERATION (3 patients)
INFLUENZA (3 patients)
DRUG EFFECT DECREASED (3 patients)
ACTIVITIES OF DAILY LIVING IMPAIRED (2 patients)
VISION BLURRED (2 patients)
RESTLESSNESS (2 patients)
NASOPHARYNGITIS (2 patients)
MULTIPLE MYELOMA (2 patients)
CEREBROVASCULAR ACCIDENT (2 patients)
COORDINATION ABNORMAL (2 patients)
DRUG INEFFECTIVE (2 patients)
HYPOAESTHESIA (2 patients)
EPISTAXIS (2 patients)
DYSGRAPHIA (2 patients)
DYSARTHRIA (2 patients)
DRY SKIN (1 patients)
DYSPHEMIA (1 patients)
ECZEMA WEEPING (1 patients)
DRY MOUTH (1 patients)
ERYTHEMA (1 patients)
FATIGUE (1 patients)
FEELING ABNORMAL (1 patients)
GENITAL PAIN (1 patients)
HEADACHE (1 patients)
HEARING IMPAIRED (1 patients)
HEART RATE DECREASED (1 patients)
HYPERKERATOSIS (1 patients)
DRY EYE (1 patients)
HYPOREFLEXIA (1 patients)
CONSTIPATION (1 patients)
INJECTION SITE ERYTHEMA (1 patients)
INJECTION SITE IRRITATION (1 patients)
INJECTION SITE SWELLING (1 patients)
INSOMNIA (1 patients)
INTERNATIONAL NORMALISED RATIO ABNORMAL (1 patients)
LEARNING DISORDER (1 patients)
CONDITION AGGRAVATED (1 patients)
LIP SWELLING (1 patients)
LOCALISED INFECTION (1 patients)
LUNG NEOPLASM MALIGNANT (1 patients)
MEMORY IMPAIRMENT (1 patients)
APHASIA (1 patients)
ANXIETY (1 patients)
NAUSEA (1 patients)
NEOPLASM MALIGNANT (1 patients)
PRURITUS (1 patients)
PYREXIA (1 patients)
RASH (1 patients)
AMNESIA (1 patients)
RHINORRHOEA (1 patients)
SOMNOLENCE (1 patients)
SYNCOPE (1 patients)
URTICARIA (1 patients)
ACUTE SINUSITIS (1 patients)
WEIGHT INCREASED (1 patients)
WITHDRAWAL SYNDROME (1 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for AIRBORNE


Issue Description / Topic Timestamp
CONCERN
DRY MOUTH
Took last night have severe dry mouth 2015-11-18 06:01:39
QUESTION
INSOMNIA
I take Amitryptyline and Trazodone. When I use Airborne I cannot get to sleep. 2017-10-07 15:22:45

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about ALOPECIA and AIRBORNE, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking AIRBORNE, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in AIRBORNE. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for AIRBORNE experts. If you are a healthcare provider experienced in prescribing AIRBORNE, please register here.

Your online appointment book for Keystone Rentals & Services



© 2014 FactMed, Inc
Privacy Policy
Terms of Use